Clinical characteristics of patients with TTP-like syndromes following BMT During a 10-year period, 1 January 1989 to 31 December 1998, 17 patients were diagnosed with a TTP-like syndrome ...

The syndrome is called thrombotic thrombocytopenic purpura, or TTP, and treatment involves exchanging three to seven liters of plasma each day, at a cost of $10,000 a day.

Investigators found patients with acute coronary syndrome were 3 times more likely to die in the hospital. Patients with thrombotic thrombocytopenic purpura (TTP) face a higher risk of morbidity ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura ...

Acquired thrombotic thrombocytopenic purpura (aTTP) affects the way your blood clots and helps cause bleeding. Learn what causes aTTP and how to spot the symptoms.

Abstract Thrombotic thrombocytopenic purpura (TTP) has emerged as one of the main transplant-related complications over the last 15 years.

Our patient exhibited a typical TTP syndrome with a high titer of anti-ADAMTS13 IgG autoantibody that resolved with corticosteroids and plasma exchanges.

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

By giving their patient the correct diagnosis, clinicians avoided costlier treatments for thrombotic thrombocytopenic purpura (TTP) like plasmapheresis.

A person can develop post thrombotic syndrome after getting deep vein thrombosis. It can lead to mild symptoms or chronic pain and leg ulcers. Read more here.

Patients with thrombotic antiphospholipid syndrome appear better treated with a vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, a new meta-analysis suggests.